Dyne Therapeutics, Inc. (DYN): $18.10

0.12 (+0.67%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add DYN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 496

in industry

Dyne Therapeutics Inc (DYN) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering DYN.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
5 $47 $27 $36.4 $16.98 114.37%

The Trend in the Analyst Price Target


Over the past 84 days, DYN's average price target has gone down $0.

Over the past 211 days, DYN's average upside potential has been 86.37%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-08 5 47 27 36.40 18.71 94.55%
2021-04-22 5 47 27 36.40 17.14 112.37%
2021-04-17 5 47 27 36.40 17.45 108.6%
2021-04-10 5 47 27 36.40 16.75 117.31%
2021-04-03 5 47 27 36.40 15.94 128.36%
2021-03-20 5 47 27 36.40 15.81 130.23%
2021-03-13 5 47 27 36.40 16.84 116.15%
2021-03-06 5 47 27 36.40 15.60 133.33%
2021-02-15 5 47 27 36.40 18.61 95.59%
2021-02-13 5 47 27 36.40 18.61 95.59%
2021-02-06 4 47 27 34.25 20.49 67.15%
2021-01-30 4 47 27 34.25 19.33 77.19%
2021-01-23 4 47 27 34.25 20.20 69.55%
2021-01-16 4 47 27 34.25 28.61 19.71%
2021-01-09 4 47 27 34.25 27.13 26.24%
2021-01-02 4 47 27 34.25 21.00 63.1%
2020-12-18 4 47 27 34.25 21.16 61.86%
2020-12-10 4 47 27 34.25 19.49 75.73%
2020-12-07 4 47 27 34.25 20.71 65.38%
2020-11-28 4 47 27 34.25 19.90 72.11%
2020-10-09 4 47 27 34.25 18.64 83.74%

DYN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.3 2 3 0 0 0 5

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • DYN has a higher upside potential (average analyst target price relative to current price) than 83.68% of all US stocks.
  • Dyne Therapeutics Inc's variance in analysts' estimates is lower than 21.14% of all US stocks.
  • Dyne Therapeutics Inc's average analyst price target is higher than 75.91% of stocks in the small market cap category.
  • Dyne Therapeutics Inc's number of analysts covering the stock is greater than 68.42% of stocks in the small market cap category.

Stocks similar to Dyne Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ITOS, ORMP and SURF.

What is the outlook for DYN? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6492 seconds.